Market revenue in 2023 | USD 80.0 million |
Market revenue in 2030 | USD 154.9 million |
Growth rate | 9.9% (CAGR from 2023 to 2030) |
Largest segment | Services |
Fastest growing segment | Services |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Services, Data Sets |
Key market players worldwide | IQVIA Holdings Inc, International Business Machines Corp, Thermo Fisher Scientific Inc, PAREXEL, PerkinElmer, Icon PLC, Oracle Corp, Syneos Health, Medpace Holdings Inc |
Services was the largest segment with a revenue share of 57.63% in 2023. Horizon Databook has segmented the Middle East & Africa real world evidence solutions market based on services, data sets covering the revenue growth of each sub-segment from 2018 to 2030.
The Middle East & Africa region comprises South Africa, Israel, and Saudi Arabia. The real-world evidence solutions market in Middle East & Africa region is expected to grow over the forecast period. This can be attributed to the increasing need for integration of the healthcare system, growing focus on high return on investments, and rising need for high-quality care.
In addition, evolution of IT and increasing number of supportive initiatives to combine health records on a single platform fuel the growth of real-world evidence solutions markets. Some of the key players operating in MEA real-world evidence solutions market are IQVIA, IBM, Parexel International Corporation, and Icon plc.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account